Response to Smith and Shaw "Response to "Safety of dermatologic medications in pregnancy and lactation: An update - Part 1: Pregnancy & Part 2: Lactation""

J Am Acad Dermatol. 2024 Apr 12:S0190-9622(24)00628-5. doi: 10.1016/j.jaad.2024.04.017. Online ahead of print.
No abstract available

Keywords: dermatologic therapy; fetus; gestation; lactation; medication safety; nursing; parturition; pregnancy; rituximab.

Publication types

  • Letter